Polypharmacy is highly prevalent among the elderly, particularly women under 80, leading to a high rate of potential drug-drug interactions that frequently involve cardiovascular medications.
No takes yet. Share an insight, caveat, or question.
High rates of potential interactions in elderly polypharmacy warrant prescribing caution; leaves open whether screening improves cardiovascular outcomes.
Venturini et al. (2011) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: